
Publication
Advance Notice By-Law 2.0
Advance notice by-laws are a long-standing, commonly accepted corporate governance tool in Canada.
United States | Publication | November 8, 2021
On November 6, 2021, the Fifth Circuit Court of Appeals granted a nationwide stay of the Occupational Health and Safety Administration (OSHA)'s Emergency Temporary Standard (ETS) vaccine-or-test mandate that was issued on November 5, 2021. The court granted the nationwide stay due to "grave statutory and constitutional issues" with the mandate.
The emergency stay was requested by numerous petitioners, including the Attorneys General for the states of Texas, Louisiana, Mississippi, South Carolina, Utah and several private entities. The federal government must respond to the petitioners' motion for a permanent injunction by 5:00 pm today, to which petitioners may file their reply brief by 5:00 pm tomorrow, Tuesday, November 9, 2021.
Until the courts provide further notice, employers need not begin enforcing OSHA's vaccine-or-test mandate.
Special thanks to law clerk Michelle Avidisyans (Los Angeles) for her assistance in the preparation of this content.
Publication
Advance notice by-laws are a long-standing, commonly accepted corporate governance tool in Canada.
Publication
An Ontario court has delivered yet another unfortunate termination clause decision.
Publication
With the suspension of the USPTO’s Climate Change Mitigation Pilot, the Canadian Advanced Examination for Green Technologies mechanism can be used to accelerate examination for a corresponding Canadian application, which can then generate a work product usable for expediting examination in various patent offices around the world using the Patent Prosecution Highway (PPH), reducing the time from patent application filing to grant.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025